HCC in cirrosi CHILD C: fattori prognostici e sopravvivenza
Hepatocellular carcinoma in child-pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments.Kudo M, Osaki Y, Matsunaga T, Kasugai…
Approfondisci...
Trapianto vs resezione nel trattamento dell’HCC
Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies. Zheng Z, Liang W,…
TACE + Sorafenib se l’HCC non è resecabile : una review sistematica
Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the…
Risposta alla Tace può essere un’indicazione al trapianto
How to Decide About Liver Transplantation in Patients with Hepatocellular Carcinoma: Size and Number of Lesions or Response to TACE?Otto…
Ipoglicemizzanti orali e rischio di HCC : una meta-analisi
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis.Singh S, Singh PP, Singh AG, Murad MH,…
Fattori di rischio per morbidità dopo resezione per HCC
Risk factors for major morbidity after liver resection for hepatocellular carcinoma and strategies to reduce them.Sadamori H, Yagi T, Shinoura…
Statine riducono rischio di HCC
Statins Are Associated with a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis.Singh S, Singh PP, Singh AG,…
Performance dei criteri di Milano per trapianto in HCC migliorata dall’inserimento del parametro alfa-feto
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria.Duvoux C, Roudot-Thoraval F, Decaens T,…
Performance dei biomarkers di HCC nella cirrosi avanzata
Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C.Sterling RK, Wright EC, Morgan TR, Seeff LB,…
Resezione HCC: è giustifiacta la restrizione ai criteri AASLD/BCLC?
Resection for Hepatocellular Carcinoma: Is it justifiable to restrict this to the AASLD/BCLC criteria?Chow PK. J Gastroenterol Hepatol. 2011 Dec…
TACE per HCC: validazione dell’algoritmo di trattamento.
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.Takayasu K, Arii S, Kudo M, Ichida…
RFA vs chirurgia nel trattamento di “small HCC”: una meta-analisi
Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: A meta-analysis.Le Li, Jialin Zhang, Xiaohua Liu, Xiaohang…
Sopravvivenza e recidiva dopo RF per HCC : una meta-analisi
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.Tiong L, Maddern GJ. Br J…
Sorafenib +TACE nel trattamento dell’HCC
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. Cabrera, R., Pannu, D. S., Caridi, J., Firpi, R. J.,…
Fattori predittivi di sopravvivenza nei pz con HCC trattato con TACE
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Cabibbo G, Genco C, Di Marco V, Barbara M,…
Terapia di mantenimento con PegIntron non garantisce la prevenzione di HCC
Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C.Bruix J, Poynard T,…
Review sistematica sul downstaging dell’HCC pretrapianto
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.Gordon-Weeks AN, Snaith A,…
Management dei piccoli HCC
Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma.Naugler WE, Sonnenberg A. Liver Transpl. 2010…
IFN migliora outcome di HCC trattato
Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Singal AK, Freeman DH Jr, Anand BS. Aliment Pharmacol…
Meta-analisi dei tassi di sopravvivenza nell’HCC non trattato
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Cabibbo G, Enea M, Attanasio…
HCC non resecabile : opportuna l’indicazione al trapianto
Patients with unresectable hepatocellular carcinoma beyond milan criteria: should we perform transarterial chemoembolization or liver transplantation? Kim JM, Kwon CH,…
Metanalisi sulle tecniche di ablazione dell’HCC
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis.Germani G, Pleguezuelo M, Gurusamy…
RECIST nella valutazione dell’HCC
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Lencioni R, Llovet JM. Semin Liver Dis. 2010 Feb;30(1):52-60. The endpoint in cancer…
Impatto dell’EBM sul trattamento dell’HCC
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma. Giannini EG, Bodini G, Corbo M, Savarino V,…
